Search - tctmd.com

Displaying 1 - 20 of 205

Sort: Relevancy | Date

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

Presentation NY Valves 2024

When to Consider TAVR Explant Or Redo ADR Surgery

Presenter: Michael A. Borger

June 07, 2024

Presentation NY Valves 2024

TAVR-in-TAVR: Ready for Primetime?

Presenter: Mathew Williams

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

How to Define and Manage Subclinical Leaflet Thrombosis

Presenter: Hasan Jilaihawi

June 07, 2024

Presentation NY Valves 2024

Histopathology From Explanted Valves in Patients With HALT and RLM

Presenter: Stephanie Sellers

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Arial View of Antithrombotic Therapy Post TAVR

Presenter: Thomas Pilgrim

June 07, 2024

Presentation NY Valves 2024

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Presenter: Itsik Ben-Dor

June 07, 2024

Presentation NY Valves 2024

Acute Abdominal Aortic Perforation Following TAVI

Presenter: Luigi Salemme

June 07, 2024

Advertisement

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

National Data Point to Soaring TAVI Rates in Patients Under 65

When to Consider TAVR Explant Or Redo ADR Surgery

TAVR-in-TAVR: Ready for Primetime?

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

How to Define and Manage Subclinical Leaflet Thrombosis

Histopathology From Explanted Valves in Patients With HALT and RLM

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Arial View of Antithrombotic Therapy Post TAVR

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Acute Abdominal Aortic Perforation Following TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content